To find novel, prostate cancer specific clinically relevant AR-target genes, we integrated earlier published data based on gene expression18 in clinical prostate cancer specimens with AR-ChIP-seq data18–22,24 (Supplementary Figure S1). This evidence concerns the gene AR and Familial prostate cancer.